Article

Modifying sterilization may help in TASS

Las Vegas-Existing sterilization techniques, particularly those used in higher-volume, rapid-turnover operating rooms, may need to be modified to avoid and control future outbreaks of toxic anterior segment syndrome (TASS), Simon P. Holland, MD, FRCSC, said at the annual meeting of the American Academy of Ophthalmology here.

Reusable cannulated instruments should be avoided when possible, except for phaco tips if well-cleaned, he added, and sufficient time should be allotted to prepare and sterilize instruments between cases.

Dr. Holland, clinical professor of ophthalmology and visual sciences, University of British Columbia, Vancouver, reported the experience of a large, multi-surgeon cataract surgery clinic at which a prolonged outbreak occurred over a period of 2 years. The potential cause was endotoxin contamination of balanced salt solution (BSS).

TASS was defined as anterior segment inflammation, a fibrin and cellular response absent of vitritis usually occurring within 1 week of surgery (usually on the first day), and culture-negative intraocular biopsy results. The study included a control group of 4,800 patients who did not develop TASS despite undergoing surgery on the same day as patients who did develop it. The primary outcome measure was outbreak resolution.

Multiple interventions

Multiple interventions produced varying results, he said.

Microbiological review was obtained. Autoclave reservoirs were cultured and showed heavy contamination with endotoxin-forming gram-negative bacteria including "the usual culprits, predominantly Sphingomonas, Burkholderia, and Acinetobacter," Dr. Holland said.

Over 24 months, several changes were made at the clinic, he said.

"This is what makes teasing out the relevant data so difficult," he added.

Cleaning protocols were improved during the first month after TASS was seen. In months three to seven, no cases of TASS were diagnosed.

In month seven, a short-cycle sterilizer (Statim 5000, SciCan Inc.) was introduced and the clinic switched to bimanual phacoemulsification. Six cases of TASS followed in 2 days.

Subsequently, Dr. Holland said, "there was more intense sterilizer reservoir cleaning, the reusable tubing was discontinued, single-use phaco tips were used, the gloves were changed, filtration was added, and enzymatic cleaners" were used.

In month 13, more intense sterilizer reservoir cleaning was introduced. The filters were changed again, and wrapped cycles were used.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.